carboplatin - CISMeF

Preferred Label : carboplatin;

MeSH definition : An organoplatinum compound that possesses antineoplastic activity.;

MeSH synonym : cbdca; cis-diammine(cyclobutanedicarboxylato)platinum ii;

CISMeF synonym : diammine[cyclobutane-1,1-dicarboxylato(2-)-o,o']platinum; ribosepharm brand of carboplatin; prasfarma brand of carboplatin; neocorp brand of carboplatin; carboplat; Bristol-Myers squibb brand of carboplatin; pharmachemie brand of carboplatin; columbia brand of carboplatin; almirall brand of carboplatin; chiesi brand of carboplatin; lemery brand of carboplatin;

CISMeF acronym : JM8;

DeCS synonym : Carboplat;

MeSH hyponym : JM-8; paraplatin; ribocarbo; platinwas; ercar; neocarbo; carbotec; nealorin; NSC-241240; blastocarb; carbosin; JM 8; JM8; NSC 241240; NSC241240; Paraplatine;

MeSH CAS label : platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)-;

MeSH Related Number : 41575-94-4 (Carboplatin);

Registry Number MeSH : 41575-94-4;

Wikipedia link : https://en.wikipedia.org/wiki/Carboplatin;

Codes EINECS : 255-446-0;

Is substance : O;

UNII : BG3F62OND5;

InChIKey : OLESAACUTLOWQZ-UHFFFAOYSA-L;

Details

Origin ID

D016190;

UMLS CUI

C0079083;

ATC code(s)
- carboplatin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Carboplatin adverse reaction (disorder) [SNOMED CT concept]
- Carboplatin poisoning (disorder) [SNOMED CT concept]
- diammine[cyclobutane-1,1-dicarboxylato(2-)-o,o']platinum [Substance BNPC]
Currated CISMeF NLP mapping
- Carboplatin [ICD-11 Extension code]
- Carboplatin [ICHI extension code]
- Carboplatin [NCIt concept]
- Carboplatin (substance) [SNOMED CT concept]
Pharmacological action(s)
- antineoplastic agents [MeSH Descriptor]
- cross-linking reagents [MeSH Descriptor]
Record concept(s)
- Carboplat [MeSH concept]
- JM-8 [MeSH concept]
- NSC-241240 [MeSH concept]
- blastocarb [MeSH concept]
- carboplatin [MeSH concept]
- carbosin [MeSH concept]
- carbotec [MeSH concept]
- ercar [MeSH concept]
- nealorin [MeSH concept]
- neocarbo [MeSH concept]
- paraplatin [MeSH concept]
- platinwas [MeSH concept]
- ribocarbo [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1,2-bis(fluorophenyl)ethylenediamine)(cyclobutane-1,1-dicaroxylato)platinum(II) [MeSH Supplementary Concept]
- BIC protocol [MeSH Supplementary Concept]
- CAC protocol [MeSH Supplementary Concept]
- CCA protocol [MeSH Supplementary Concept]
- CCC protocol [MeSH Supplementary Concept]
- CE-CAP protocol [MeSH Supplementary Concept]
- CEA protocol [MeSH Supplementary Concept]
- CEC protocol [MeSH Supplementary Concept]
- CEO-PE protocol [MeSH Supplementary Concept]
- CEV regimen [MeSH Supplementary Concept]
- CHAC-1 protocol [MeSH Supplementary Concept]
- CIV protocol [MeSH Supplementary Concept]
- CMCp protocol [MeSH Supplementary Concept]
- CPVP protocol [MeSH Supplementary Concept]
- CTCb regimen [MeSH Supplementary Concept]
- CTEC protocol [MeSH Supplementary Concept]
- Carbo-MVE protocol [MeSH Supplementary Concept]
- D-CECaT regimen [MeSH Supplementary Concept]
- DHACT protocol [MeSH Supplementary Concept]
- DN604 [MeSH Supplementary Concept]
- DWA 2114 [MeSH Supplementary Concept]
- EAC regimen [MeSH Supplementary Concept]
- EAP-II protocol [MeSH Supplementary Concept]
- ECarboX protocol [MeSH Supplementary Concept]
- FCC protocol [MeSH Supplementary Concept]
- FLEC protocol [MeSH Supplementary Concept]
- ICE protocol 2 [MeSH Supplementary Concept]
- ICE protocol 3 [MeSH Supplementary Concept]
- ICE protocol 5 [MeSH Supplementary Concept]
- ICE protocol 6 [MeSH Supplementary Concept]
- JAC protocol [MeSH Supplementary Concept]
- JEB protocol [MeSH Supplementary Concept]
- JET protocol [MeSH Supplementary Concept]
- LCF protocol [MeSH Supplementary Concept]
- LSG15 regimen [MeSH Supplementary Concept]
- M-CAVI protocol [MeSH Supplementary Concept]
- MCNO regimen [MeSH Supplementary Concept]
- MEC regimen [MeSH Supplementary Concept]
- MECA protocol [MeSH Supplementary Concept]
- MECCA protocol [MeSH Supplementary Concept]
- MECP protocol [MeSH Supplementary Concept]
- MIMOC protocol [MeSH Supplementary Concept]
- MVC regimen [MeSH Supplementary Concept]
- MVMJ protocol [MeSH Supplementary Concept]
- MiCMA protocol [MeSH Supplementary Concept]
- NK 121 [MeSH Supplementary Concept]
- OMEC regimen [MeSH Supplementary Concept]
- OPEC OJEC protocol [MeSH Supplementary Concept]
- PC protocol [MeSH Supplementary Concept]
- PP regimen [MeSH Supplementary Concept]
- Pt(en)(CBDCA-O,O') [MeSH Supplementary Concept]
- STAMP V regimen [MeSH Supplementary Concept]
- TIC protocol [MeSH Supplementary Concept]
- TMJ protocol [MeSH Supplementary Concept]
- VAC combination [MeSH Supplementary Concept]
- VCE protocol [MeSH Supplementary Concept]
- VIC-E protocol [MeSH Supplementary Concept]
- VIMP protocol [MeSH Supplementary Concept]
- caN protocol [MeSH Supplementary Concept]
- carboplatin-DNA adduct [MeSH Supplementary Concept]
- diamminecyclobutane-1,1-dicarboxylatodihydroxyplatinum(IV) [MeSH Supplementary Concept]
- enloplatin [MeSH Supplementary Concept]
- regimen B [MeSH Supplementary Concept]
- zeniplatin [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Carboplatin [ICD-11 Extension code]
- Carboplatin [NCIt concept]
- Carboplatin (substance) [SNOMED CT concept]
- Product containing carboplatin (medicinal product) [SNOMED CT concept]
- carboplatin [ATC Code]
- diammine[cyclobutane-1,1-dicarboxylato(2-)-o,o']platinum [Substance BNPC]
Validated automatic mappings to BTNT
- carboplatin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients